$3.54T
Total marketcap
$137.49B
Total volume
BTC 62.56%     ETH 9.47%
Dominance

NuCana NCNA Stock

0.06 USD {{ price }} 0.331674% {{change_pct}}%
Exchange
NasdaqCM
Market Cap
23.09M USD
LOW - HIGH [24H]
0.06 - 0.07 USD
VOLUME [24H]
398.41M USD
{{ volume }}
P/E Ratio
0
Earnings per share
-5.11 USD

NuCana Price Chart

NuCana NCNA Financial and Trading Overview

NuCana stock price 0.06 USD
Previous Close 0.06 USD
Open 0.07 USD
Bid 0.06 USD x 900
Ask 0.1 USD x 400
Day's Range 0.06 - 0.07 USD
52 Week Range 0.03 - 10.79 USD
Volume 316.81M USD
Avg. Volume 186.79M USD
Market Cap 23.51M USD
Beta (5Y Monthly) 1.254
PE Ratio (TTM) N/A
EPS (TTM) -5.11 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

NCNA Valuation Measures

Enterprise Value 4.91M USD
Trailing P/E N/A
Forward P/E -0.0065323436
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) 0.08940493
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.286

Trading Information

NuCana Stock Price History

Beta (5Y Monthly) 1.254
52-Week Change -98.064%
S&P500 52-Week Change 12.15%
52 Week High 10.79 USD
52 Week Low 0.03 USD
50-Day Moving Average 0.15 USD
200-Day Moving Average 1.02 USD

NCNA Share Statistics

Avg. Volume (3 month) 186.79M USD
Avg. Daily Volume (10-Days) 238.41M USD
Shares Outstanding 381.62M
Float 149.77M
Short Ratio 0.02
% Held by Insiders 0.0030%
% Held by Institutions 0.12%
Shares Short 4.61M
Short % of Float N/A
Short % of Shares Outstanding 76.07%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 1:25

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2024
Most Recent Quarter (mrq) March 31, 2025
Next Fiscal Year End December 31, 2025

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -59.80%
Return on Equity (ttm) -204.59%

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA -17171000 USD
Net Income Avi to Common (ttm) -14632000 USD
Diluted EPS (ttm) -5.11
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 3.95M USD
Total Cash Per Share (mrq) 0.03 USD
Total Debt (mrq) 173K USD
Total Debt/Equity (mrq) 4.15 USD
Current Ratio (mrq) 1.25
Book Value Per Share (mrq) 0.689

Cash Flow Statement

Operating Cash Flow (ttm) -16344000 USD
Levered Free Cash Flow (ttm) -12455625 USD

Profile of NuCana

Country United States
State N/A
City Edinburgh
Address 3 Lochside Way
ZIP EH12 9DT
Phone 44 13 1357 1111
Website https://www.nucana.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 20

NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer. It applies its ProTide technology to transform prescribed chemotherapy agents and nucleoside analogs into medicines. The company is developing medicines to overcome the limitations of nucleoside analogs and generate anti-cancer metabolites in cancer cells. Its pipeline includes NUC-3373, a chemical entity derived from the nucleoside analog 5-fluorouracil that is in Phase 1b/2 study in patients with metastatic colorectal cancer; Phase 2 clinical trial for the second-line treatment of patients with advanced colorectal cancer; and Phase 1 modular clinical trial for patients with advanced solid tumors and lung cancer. The company is also developing NUC-7738, a ProTide transformation of 3'-deoxyadenosine, which is in the Phase 2 part of a Phase 1/2 clinical trial for patients with advanced solid tumors. The company has an assignment, license, and collaboration agreement with Cardiff ProTides Ltd to discover, drug design, and in vitro screen purine and pyrimidine-based nucleosides as potential drug candidates. The company was formerly known as NuCana BioMed Limited and changed its name to NuCana plc in August 2017. NuCana plc was incorporated in 1997 and is based in Edinburgh, the United Kingdom.

Q&A For NuCana Stock

What is a current NCNA stock price?

NuCana NCNA stock price today per share is 0.06 USD.

How to purchase NuCana stock?

You can buy NCNA shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for NuCana?

The stock symbol or ticker of NuCana is NCNA.

Which industry does the NuCana company belong to?

The NuCana industry is Biotechnology.

How many shares does NuCana have in circulation?

The max supply of NuCana shares is 381.62M.

What is NuCana Price to Earnings Ratio (PE Ratio)?

NuCana PE Ratio is now.

What was NuCana earnings per share over the trailing 12 months (TTM)?

NuCana EPS is -5.11 USD over the trailing 12 months.

Which sector does the NuCana company belong to?

The NuCana sector is Healthcare.

NuCana NCNA included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 20571.71 USD
-0.19
4.13B USD 20495.14 USD 20653.86 USD 4.13B USD
NASDAQ Global Select Market Com NQGS 10066.52 USD
-0.19
10031.2 USD 10105.21 USD
Nasdaq Health Care IXHC 998.33 USD
+0.54
988.48 USD 998.34 USD